share_log

Lipella Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Yoshimura Naoki

SEC ·  Mar 20, 2024 06:27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more